Recruiting Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more Locations UC San Diego Moores Cancer Center — La Jolla, California, United States Keck Medicine of USC Koreatown — Los Angeles, California, United States Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States View all 26 locations View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial NCT07576725 Conditions Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more Locations Uganda Cancer Institute — Kampala, Uganda View Trial Details
Active, Not Recruiting Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers NCT03816332 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +42 more Locations Moffitt Cancer Center - McKinley Campus — Tampa, Florida, United States Moffitt Cancer Center — Tampa, Florida, United States Northwestern University — Chicago, Illinois, United States Johns Hopkins University/Sidney Kimmel Cancer Center — Baltimore, Maryland, United States View more locations Show fewer locations Loading locations... View Trial Details
